ReadYourDNA

Pimozide (Orap)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Pimozide

What it is

Pimozide is an older antipsychotic that blocks dopamine D2 receptors. It is used mainly for severe tics in Tourette's syndrome when other treatments have not helped, and in some countries for certain psychoses. It can affect the heart rhythm, so it is used with care. It is sold as Orap, among other names.

How genes come into it

Pimozide is broken down by the liver enzymes CYP3A4 and CYP2D6. People with no working CYP2D6 copies (poor metabolizers) reach higher levels, and because high levels can lengthen the QT interval of the heartbeat, the US drug label discusses CYP2D6 genotyping. DPWG has published a guideline on CYP2D6 and pimozide, and the US FDA lists the pair. Only a few studies have looked at genes for this medicine.

Published guidelines

Clinical guidelines that name a gene for Pimozide. They sort people into groups by the gene copies they carry.

DPWG guideline: CYP2D6. CYP2D6 activity score 0 to 6 or more. 2024.

US FDA: CYP2D6. CYP2D6 activity score 0.

US FDA: CYP2D6. CYP2D6 activity score 0. Data that Support Therapeutic Management Recommendations.

What research found

Every published finding on gene variants and Pimozide. Upload your DNA file to see which of these rows apply to you.

Metabolism (3 findings)

Studies of how quickly the body processes this medication.

CYP3A4 CYP3A4*1, CYP3A4*22: CYP3A4 *22 is associated with decreased concentrations of pimozide in people with Psychotic Disorders as compared to CYP3A4 *1/*1.

CYP2D6 CYP2D6 poor metabolizer: CYP2D6 poor metabolizer is associated with increased concentrations of pimozide in healthy individuals as compared to CYP2D6 normal metabolizer.

CYP3A4 CYP3A4*1, CYP3A4*22: CYP3A4 *22 is not associated with dose-adjusted trough concentrations of antipsychotics, aripiprazole, haloperidol, pimozide or risperidone in people with Psychotic Disorders as compared to CYP3A4 *1.

Dosing (2 findings)

Studies of how much of the drug people needed or tolerated.

CYP2D6 CYP2D6 poor metabolizers: CYP2D6 poor metabolizer is associated with decreased dose of pimozide.

CYP3A4 CYP3A4*1, CYP3A4*22: CYP3A4 *22 is not associated with dose of aripiprazole, haloperidol, pimozide or risperidone in people with Psychotic Disorders as compared to CYP3A4 *1/*1.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Abilify (Antipsychotics)

Antipsychotics (class) (Antipsychotics)

Bromperidol (Antipsychotics)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com